Petrus Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-515
Closed -$425K 626
2025
Q1
$425K Buy
+515
New +$429K 0.04% 268
2024
Q4
Sell
-754
Closed -$668K 673
2024
Q3
$668K Buy
+754
New +$678K 0.07% 116
2023
Q1
Sell
-766
Closed -$280K 635
2022
Q4
$280K Buy
+766
New +$272K 0.04% 296
2017
Q1
Sell
-4,205
Closed -$309K 204
2016
Q4
$309K Buy
+4,205
New +$313K 0.08% 87

Other funds holding LLY

Petrus Trust Company's LLY Position: Q2 2025 in Review

Petrus Trust Company sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 515 shares — an estimated $425K sold.

Petrus Trust Company first reported a position in LLY in Q4 2016 and held it in 4 quarters. The position peaked at $668K in Q3 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Petrus Trust Company reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Petrus Trust Company sold 515 Eli Lilly shares in Q2 2025, an estimated $425K.
  • Petrus Trust Company first reported a position in Eli Lilly in Q4 2016 and held it in 4 quarters.
  • Petrus Trust Company's Eli Lilly position peaked at $668K in Q3 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Petrus Trust Company's 13F filing for Q2 2025, filed 14 Aug 2025.